Abstract
Our objective was to assess the loss of E-cadherin (EC) as a diagnostic marker or a predictor of prognosis. We stained 276 breast carcinomas with monoclonal antibodies to EC (invasive lobular carcinomas [ILC] and variants, 59; invasive ductal carcinoma and ductal special types [IDC], 204; tubulolobular carcinoma [TLC], 4; and invasive carcinoma [IC], uncertain whether lobular or ductal type, 9). The results were as follows: EC+IDCs, 99.5%; EC-ILCs, 90%; EC+ILCs, 10%; EC+pleomorphic ILCs, 20%; EC-ICs, 44%. All 4 TLCs showed positive tubules while cords were negative. Statistically a correlation of EC loss with a positive diagnosis of ILC was found but there was no correlation with any prognostic tumor variables. A negative EC stain confirms the diagnosis of ILC (specificity, 97.7%; negative predictive value, 96.8%; sensitivity, 88.1%; positive predictive value, 91.2%). EC is helpful in classifying cases with indeterminate histologic features. EC loss is uncommon in nonlobular carcinomas with no correlation to currently established prognostic variables.
Citations
Jan 18, 2014·Der Pathologe·H-P SinnS Aulmann
Feb 27, 2014·Clinical & Experimental Metastasis·Jacqueline JonesClayton Yates
Sep 4, 2012·Annals of Surgical Oncology·Matthew DixonNatalie Coburn
Jul 31, 2007·Journal of Medical Genetics·S MasciariD Huntsman
Nov 29, 2007·Breast Cancer Research and Treatment·Ritse M MannCarla Boetes
Mar 1, 2008·BMC Cancer·Vanessa F Z MarinhoHelenice Gobbi
Jul 9, 2009·Langmuir : the ACS Journal of Surfaces and Colloids·Jonathan SilvestreDeborah E Leckband
Sep 16, 2009·BMC Cancer·Chandra P PrasadRanju Ralhan
Jun 5, 2012·PloS One·Jeroen F VermeulenPatrick W B Derksen
Nov 14, 2008·Breast Cancer Research and Treatment·Niall McinerneyElinor Sawyer
Sep 17, 2013·Clinical Radiology·M MuttalibM Hajaj
Sep 29, 2009·Der Pathologe·D BaumhoerG Jundt
Jul 9, 2013·Pathology Oncology Research : POR·Golan BubisLea Rath-Wolfson
Feb 4, 2016·The Breast Journal·Muhammad Asad ParvaizTapan Sircar
Jan 16, 2016·Histopathology·Rita Canas-Marques, Stuart J Schnitt
Sep 1, 2012·Surgical Pathology Clinics·Marianna Philippidou, Sarah E Pinder
Nov 30, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·E Wilcz-VillegaM O'Sullivan
Dec 18, 2008·Pathology·Takuya MoriyaPuay-Hoon Tan
Jul 1, 2015·Breast Cancer Research and Treatment·Sai Yin CheungPuay Hoon Tan
Jul 26, 2015·Clinical Breast Cancer·Khalid Al-BaimaniAngel Arnaout
Aug 15, 2014·BMC Cancer·Yuan-Chiang ChungWei-Ting Chao
Nov 2, 2016·European Journal of Clinical Investigation·Yuan-Chiang ChungWei-Ting Chao
Apr 25, 2015·Revista da Associação Médica Brasileira·Claudia RossettiFernando Fonseca
Jun 30, 2018·PloS One·Francesca BuontempoGastone Castellani
Jun 28, 2011·Electrophoresis·Marijana RucevicDjuro Josic
Dec 18, 2013·SpringerPlus·Gisela Lg MenezesRuud M Pijnappel
Apr 2, 2008·The American Journal of Surgical Pathology·Leonard Da SilvaPeter T Simpson
Nov 11, 2010·British Journal of Cancer·P QuerzoliS Alberti
Dec 18, 2010·The American Journal of Surgical Pathology·Fouad Boulos, Faysal Fedda
Feb 11, 2015·Nature Reviews. Clinical Oncology·Konstantinos TryfonidisFatima Cardoso
Jul 1, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Young J ChoiAli K Riba
May 29, 2014·Tissue Barriers·Hui YouStelios T Andreadis